Miami-based eMed, which focuses on health management for the GLP-1 and GIP population, said Yaccarino’s experience will be critical as it expands its services to accommodate new employers and government partnerships.

Though Yaccarino does not have experience in health tech, eMed said in a press release that they sought her out for her "undeniable ability to negotiate new partnerships."

Linda Yaccarino, less than a month after stepping down as CEO of Elon Musk’s X, has found her next gig. Yaccarino has been named CEO of Miami-based eMed Population Health, which calls itself “the leading digital health platform for GLP-1/GIP population health management.